NCT01824420View on ClinicalTrials.gov

Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome

PHASE4CompletedINTERVENTIONAL

Enrollment

129

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions

Overactive Bladder

Interventions

DRUG

Detrusitol 4mg QD and Oxybutynin ER 5mg QD

Study group

DRUG

Detrusitol 4mg QD

Control group

Trial Locations (1)

970

Buddhist Tzu Chi General Hospital, Hualien City

All Listed Sponsors

lead

Buddhist Tzu Chi General Hospital

OTHER

NCT01824420 - Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome | Biotech Hunter | Biotech Hunter